🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open label, 2-period, sequential study to determine the impact of multip...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00384280
Treatments Being Tested
An open label, 2-period, sequential study to determine the impact of multip...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00384917
Treatments Being Tested
This study is an open-label, single-dose, parallel group study to evaluate ...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00407173
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics (PK) of HCV-796...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00314054
Treatments Being Tested
This is a phase 2, randomized, open-label study comparing the safety, antiv...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-10
Trial ID
NCT00367887
Treatments Being Tested
The purpose of the study is to assess the safety and tolerability of ascend...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00385190
Treatments Being Tested
To evaluate the potential PK interaction of multiple oral doses of HCV-796 ...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00410254
To evaluate the potential pharmacokinetic (PK) interaction of multiple oral...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00500721
Treatments Being Tested